Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 4 Stomach Neoplasms 2 Lymphoma, B-Cell, Marginal Zone 2 Persistence of Infection With Helicobacter Pylori 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Infections 1 Familial primary gastric lymphoma 1 Drug-Related Side Effects and Adverse Reactions 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

tocilizumab 1 golimumab 1 gilteritinib 1 Tumor Necrosis Factor Inhibitors 1 Trimethoprim, Sulfamethoxazole Drug Combination 1 Saline Solution 1 Probiotics 1 Polymerase Chain Reaction 1 Observation 1 Levofloxacin 1 Infliximab 1 Immunoenzyme Techniques 1 Etanercept 1 Docosahexaenoic Acids 1 Clarithromycin 1 Cefoxitin 1 Cefepime 1 Bronchoscopy 1 Bronchoalveolar Lavage 1 Antibiotic Prophylaxis 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Infections × Clarithromycin × Clear all

NCT02624440 2015-12-08

SUTRICA

Aalborg University Hospital

Phase 2 Unknown

Infections, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡